The iconic model graced the cover of British vogueSeptember issue, with an accompanying profile by Associate Editor Sarah Harris. In the story, Evangelista opened up about her slow re-emergence into the public eye after announcing in September 2021 that she had developed paradoxical adipose hyperplasia following CoolSculpting treatment. The condition is a rare side effect of the procedure in which fat cells grow instead of shrink as expected. She also discussed her decision to seek out CoolSculpting initially, as well as her life and career today.
“These CoolSculpting ads were on all the time, on CNN, on MSNBC, over and over, and they were like, ‘Do you like what you see in the mirror?’ They were talking to me. It was about stubborn fat in areas that wouldn’t move. He was saying no downtime, no surgery and… I drank the magic potion, and I would because I’m kinda conceited,” she said. “So I went — and it backfired on me.”
When Evangelista first spoke of experience last September, she announced that she had filed a lawsuit against CoolSculpting’s parent company, Zeltiq, which is owned by pharmaceutical conglomerate Allergan. The lawsuit has since been settled. Since September 2021, Evangelista has starred in a Fendi campaign in July and appeared on the cover of People magazine in February.